Bottom line
LOGSX vs PRHSX: the short answer
LOGSX (Live Oak Health Sciences Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds.
But PRHSX is far broader, holding 279 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
PRHSX is cheaper at 0.83% vs 1.04% — a difference of $21 a year per $10,000 invested.
Over five years, LOGSX returned +8.1% a year vs +4.2% for PRHSX.
Updated Nov 19, 2026
LOGSX vs PRHSX side by side
| LOGSX | PRHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Oak Associates | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.04% | 0.83% |
| Annual cost per $10k | $104 | $83 |
| 10-yr cost on $10k (prospectus) | $1,271 | $1,025 |
| Max front load | — | — |
| 12b-1 fee | — | — |
| 1-yr return | +19.6% | +17.7% |
| 5-yr return (annualized) | +8.1% | +4.2% |
| 10-yr return (annualized) | +7.3% | +9.1% |
| Best quarter | +13.4% | +23.5% |
| Worst quarter | −13.1% | −15.8% |
| Net assets (fund) | $56.1M | $11.9B |
| Number of holdings | 28 | 279 |
| Portfolio turnover | 24% | 62% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | LOGSX | PRHSX | Difference |
|---|---|---|---|
| 2025 | +19.6% | +17.7% | +1.9% |
| 2024 | +0.2% | +1.8% | −1.7% |
| 2023 | +1.2% | +3.1% | −1.9% |
| 2022 | +3.7% | −12.2% | +15.9% |
| 2021 | +17.5% | +13.3% | +4.2% |
| 2020 | +6.0% | +30.1% | −24.1% |
| 2019 | +19.0% | +29.1% | −10.1% |
| 2018 | −4.0% | +1.2% | −5.2% |
| 2017 | +13.4% | +28.0% | −14.5% |
| 2016 | −0.4% | −10.4% | +10.0% |
Source: Fund prospectus bar charts
Holdings overlap
9 of LOGSX's top 25 holdings also appear in PRHSX's top 25.
| Holding | LOGSX | PRHSX |
|---|---|---|
| Cardinal Health Inc | 5.86% | 1.03% |
| Amgen Inc | 4.86% | 1.82% |
| Bristol-myers Squibb Company | 4.02% | 2.11% |
| Johnson & Johnson | 3.77% | 6.63% |
| Gilead Sciences Inc | 3.50% | 2.82% |
| Vertex Pharmaceuticals Inc | 3.26% | 2.28% |
| Merck & Company Inc | 3.16% | 4.01% |
| Intuitive Surgical Inc | 2.99% | 1.87% |
| Eli Lilly & Company | 1.99% | 14.28% |
Source: SEC Form N-PORT
LOGSX top 10
- N/a — 6.91%
- Cardinal Health Inc — 5.86%
- Jazz Pharmaceuticals Plc — 5.77%
- United Therapeutics Corp — 5.11%
- Exelixis Inc — 4.95%
- Amgen Inc — 4.86%
- Lantheus Holdings Inc — 4.68%
- Novartis Ag — 4.67%
- Mckesson Corp — 4.53%
- Cencora Inc — 4.46%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between LOGSX and PRHSX?
Which is cheaper, LOGSX or PRHSX?
Should I own both LOGSX and PRHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.